Agios Presents Preclinical Data from Lead Programs at ASH
December 09, 2013 at 21:00 PM EST
Agios Pharmaceuticals (NASDAQ: AGIO ) today announced that data from its lead programs were highlighted at the American Society of Hematology (ASH) Annual Meeting this week in New Orleans.